The World Health Organization has identified four drugs, including remadecivir and hydroxychloroquine (HCQ), to be much less effective in treating corona virus-infected patients.
The World Health Organization (WHO) conducted a detailed test on how effective four particular drugs are in the treatment of Covid-19.
Remadecivir was the first drug that was first used to treat the coronavirus. This drug was also recently used in the treatment of US President Donald Trump.
Gilead, the maker of Remedesivir, has rejected the results of the WHO study.
Gilead issued a statement saying that the findings of the study do not match those of other studies and these results are yet to be reviewed.
WHO SAYS WHO'S STUDY
The WHO tested a total of four drugs during the Solidarity trial. Including remdesivir , hydroxychloroquine, auto-immune drug interferon, and a combination of HIV drugs lopinavir and ritonavir.
The low-cost steroid dexamethasone used in the treatment of severe Covid-19 patients in Britain has not been included in this study.
These four drugs were tested in 11,266 adult patients in 500 hospitals in 30 different countries.
WHO results have found that these drugs have not proved effective in saving patients' lives and also reducing the days of infection. However, these results are yet to be reviewed.
WHO Chief Scientist Soumya Swaminathan said on Wednesday that the testing of hydroxychloroquine and lopinavir and ritonavir was stopped in June as they had already proved ineffective. However, tests on other drugs were continued.
The results of the World Health Organization are completely different from the results of Gilead's study last month. Gilead had said that the time to recover from comrades virus is reduced by five days compared to patients given placebo. Gilead's trial involved 1000 patients.
Gilead's response
Gilead Sciences has dismissed the WHO results, saying, "This data looks inconsistent." The benefits of remdesivir are evidenced by more concrete evidence from academic and controlled studies published in several journals.
"We are concerned that this open (open) labeled global test data has not gone through rigorous review, which is necessary for such useful scientific discussion."
In the United States, the use of remdesivir has been allowed in an emergency from May 1. After this, its use was also approved in many other countries.
At the same time, hydroxychloroquine is used on the instructions of the doctor to protect against coronavirus infection. However, there is no clear evidence of how effective it is.
Looking at these results, Dr. Swaminathan says, "We are considering monoclonal antibodies and some new anti-viral drugs that have been developed in the last few months."
DGCA Action: DGCA's big action on SpiceJet, 50 percent flights banned for 8 weeks
Action Against SpiceJet: The Directorate General of Civil Aviation (DGCA), taking major action on
Twitter Blue Subscription: Microblogging website Twitter is used for free. Twitter will soon laun
Flood of dengue patients: Platelets start depleting suddenly; A few hours of delay can happen
Dengue cases are increasing. You must be wondering where, when, and how… we have not heard
BSF has given the latest information about the situation in Murshidabad, West Bengal after the vi
The results of the Lok Sabha elections have been announced. This time, 280 candidates have reache
If you are planning to start your investment journey, start now. Veteran investor Warren Buffett
Prime Minister Narendra Modi will inaugurate the three-day 'Raisina Dialogue' on Monday. It is In
The head of the data analyst department of Congress raised questions about the old pension system!
Amid the election atmosphere in the country, many promises and issues are coming to the fore. The
New Delhi: Amidst the growing cases of Corona, Delhi Chief Minister Arvind Kejriwal held a review
UEFA Champions League: Karim Benzema dashes hopes of Liverpool's return by scoring a goal
Following a 7–0 win against Manchester United in the English Premier League, Liverpool fans
